SEC Form 4 · accession 0001179110-16-029921
BeOne Medicines Ltd. · ONC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Donald W. Glazer
Director
Period of report
Sep 19, 2016
Accepted (ET)
Sep 21, 2016 · 9:11 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001651308
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| American Depositary Shares (each represent 13 Ordinary Shar)F2,F3 | Sep 19, 2016 | S | 40,791 | $31.56 | D | 151,516 | I | See footnote |
| American Depositary Shares (each represent 13 Ordinary Shar)F4,F3 | Sep 19, 2016 | S | 1,900 | $32.17 | D | 149,616 | I | See footnote |
| American Depositary Shares (each represent 13 Ordinary Shar)F5,F3 | Sep 20, 2016 | S | 8,243 | $31.01 | D | 141,373 | I | See footnote |
| American Depositary Shares (each represent 13 Ordinary Shar)F6,F3 | Sep 21, 2016 | S | 16,318 | $31.19 | D | 125,055 | I | See footnote |
| Ordinary SharesF8 | Jul 7, 2016 | G | 250,000 | $0.00 | D | 4,882,000 | D | |
| Ordinary SharesF9 | Jul 14, 2016 | G | 3 | $0.00 | D | 4,881,997 | D | |
| Ordinary SharesF7 | holding | — | — | — | 9 | I | See footnote |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- F2The price reported in column 4 is a weighted average price. These American Depositary Shares were sold in multiple transactions at prices ranging from $31.00 to $32.00, inclusive. The Reporting Person has provided the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price within the range.
- F3These American Depositary Shares are held for the benefit of the Reporting Person in a Roth IRA account at Fidelity Management Trust Company.
- F4The price reported in column 4 is a weighted average price. These American Depositary Shares were sold in multiple transactions at prices ranging from $32.01 to $32.30, inclusive. The Reporting Person has provided the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price within the range.
- F5The price reported in column 4 is a weighted average price. These American Depositary Shares were sold in multiple transactions at prices ranging from $31.00 to $31.13, inclusive. The Reporting Person has provided the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price within the range.
- F6The price reported in column 4 is a weighted average price. These American Depositary Shares were sold in multiple transactions at prices ranging from $31.00 to $31.50, inclusive. The Reporting Person has provided the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price within the range.
- F7These shares are held for the benefit of the Reporting Person in a Roth IRA PENSCO trust account.
- F8Bona fide gift of shares which is exempt from Section 16(b) of the Exchange Act pursuant to Rule 16b-5.
- F9Bona fide gift of shares which is exempt from Section 16(b) of the Exchange Act pursuant to Rule 16b-5.